MME and endometrioid stromal sarcoma: CD10—also referred to as the acute lymphoblastic leukemia antigen—is a neutral endopeptidase located on the cell surface that inactivates biologically active peptides and may represent a molecular marker that correlates with the prognosis of ESS patients [55].